Search results
Results from the WOW.Com Content Network
The result is a lifetime risk and a five-year risk based on factors that have been tied to a higher risk of breast cancer. For comparison, it also gives an average risk for U.S. women of the same ...
She uses a free interactive tool with all her patients to determine their risk level: the Tyrer-Cuzick Risk Assessment Calculator for breast cancer. The tool looks at personal, familial, and ...
The Tyrer-Cuzik Model and the Black Women's Health Study (BWHS) Breast Cancer Risk Calculator also include race and ethnicity in the assessment. The BOADICEA calculates risk for breast and for ...
Your Disease Risk is a publicly available health risk assessment tool on the Internet. [1] Launched in early 2000 and continually updated, the site offers risk assessments for twelve different cancers and four other important chronic diseases: heart disease, stroke, diabetes, and osteoporosis.
The objective of cancer screening is to detect cancer before symptoms appear, involving various methods such as blood tests, urine tests, DNA tests, and medical imaging. [1] [2] The purpose of screening is early cancer detection, to make the cancer easier to treat and extending life expectancy. [3]
The Nottingham prognostic index (NPI) is used to determine prognosis following surgery for breast cancer. [1] [2] Its value is calculated using three pathological criteria: the size of the tumour; the number of involved lymph nodes; and the grade of the tumour. [1] It is calculated to select patients for adjuvant treatment.
For a physician, this score is helpful in deciding how aggressively to treat a condition. For example, a patient may have cancer with comorbid heart disease and diabetes. These comorbidities may be so severe that the costs and risks of cancer treatment would outweigh its short-term benefit.
In medicine (oncology and other fields), performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. This measure is used to determine whether they can receive chemotherapy, whether dose adjustment is necessary, and as a measure for the required intensity of palliative care.